Lavipharm Group
Industry
- Pharmaceuticals
- OTC, Consumer
- Drug Delivery
Latest on Lavipharm Group
Scrip regularly covers business development and deal making in the biopharmaceutical industry. Asia Deal Watch is supported by deal intelligence from Biomedtracker. Biocytogen Licenses Antibodies For
The Greek government is pushing forth with negative and positive drug lists as a way to cut public pharmaceutical expenditure from about €4.3 billion for 2010 to €3.4 billion in 2011. Public pharma ex
The US FDAis requiring 16 manufacturers of 24 branded and generic opioid medicines to jointly develop a classwide risk evaluation and mitigation strategy (REMS) to reduce deaths and serious injuries r
Teva Pharmaceutical Industrieshas received US FDA approval and started shipping its fentanyl [transdermal] patches, in 25, 50, 75 and 100 μg/hour doses, AB-rated generic versions of Ortho-McNeil's